An association between the BRAFV600E mutation and the clinicopathological progression
of papillary thyroid microcarcinoma (PTMC) has been suggested. We aimed to summarize …

Background Papillary thyroid carcinoma (PTC) is an indolent disease with favorable
outcomes. The non-surgical treatment approach known as active surveillance (AS) has been …

Background Current guidelines recommend the use of conventional US for risk stratification
and management of thyroid nodules. However, fine-needle aspiration (FNA) is often …

Background: Delays in treatment for thyroid cancer (TC) have been associated with higher
overall mortality rates. However, few studies have explored the impact of health disparities …

Introduction Delays in surgery and their impact on survival in papillary thyroid cancer (PTC)
is unclear. We sought to investigate the association between time to surgery and survival in …

Introduction Thyroid cancer incidence has increased substantially in the past 4 decades,
estimated at 3.5% annually. Incidence is highest in white patients, yet black patients have …

Introduction Prior studies have demonstrated insurance-based disparities in the treatment of
well-differentiated thyroid cancer. However, it remains unclear whether these disparities …

Background The coronavirus disease 2019 (COVID-19) severely hindered the timely receipt
of health care for patients with cancer, especially female patients. Depression and anxiety …

Extrathyroidal extension (ETE) in patients with papillary thyroid carcinoma (PTC) is an
indication of disease progression and can influence treatment aggressiveness. This meta …

Background The COVID-19 pandemic profoundly impacted the delivery of care and timing of
elective surgical procedures. Most endocrine-related operations were considered elective …